Blazing a new trail for early-stage innovation: Purdue announces creation of Low Institute for Therapeutics (LIFT) through a generous gift by Phil and Joan Low
This story is part of an initiative led by the Central Indiana Corporate Partnership (CICP) to highlight entrepreneurship and innovation across Indiana’s universities. Learn more about the initiative here. The creation of the Low Institute for Therapeutics, which will work toward accelerating lifesaving therapeutics from the lab and into the world by funding necessary early-stage trials in partnership with Purdue University and Purdue Research Foundation, was announced Tuesday (April 29). The announcement was signed by (from left) Philip Low, Purdue's Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry; Purdue Innovates Senior Vice President Brooke Beier; and Purdue President Mung Chiang. (Purdue University photo/Kelsey Lefever) WEST LAFAYETTE, Ind. — Prostate cancer. Malaria. Influenza. All diseases one step closer to eradication thanks to the tireless, lifelong efforts of professor Philip Low. Now he’s [...]
